Thalia Therapeutics

THAT ORD GBP0.04
Create an alert
Sell0.55p
Buy0.60p
No change
Last updated today at
Trade

Key metrics

Open0.58p
Previous close0.58p
Market cap£10.21m
P/E ratio-
Volume187,256
Dividend yield0.00%
EMS300000

Company information

Thalia Therapeutics PLC, formerly N4 Pharma plc, is a biotechnology company developing RNA-based therapeutics and delivery technologies in oncology and cardiovascular disease. The Company is developing proprietary RNA ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue1.78bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Accounts to trade in

Explore the accounts you can trade this stock in.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.